National Health Investors, Inc. (NYSE:NHI) Given Consensus Recommendation of “Moderate Buy” by Brokerages

National Health Investors, Inc. (NYSE:NHI) has been assigned an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among analysts that have covered the stock in the last year is $83.8571.

NHI has been the subject of several research analyst reports. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Wells Fargo & Company lowered their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. BMO Capital Markets cut their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft reduced their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Finally, Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th.

National Health Investors Price Performance

Shares of NYSE NHI opened at $71.23 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The firm has a fifty day moving average of $75.23 and a 200 day moving average of $79.37. The firm has a market cap of $3.50 billion, a PE ratio of 20.59, a PEG ratio of 3.24 and a beta of 0.51. National Health Investors has a one year low of $67.94 and a one year high of $91.38.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 11.01%. The business had revenue of $121.32 million for the quarter. During the same period in the previous year, the business earned $1.22 earnings per share. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts predict that National Health Investors will post 4.77 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio is currently 106.36%.

Insider Buying and Selling at National Health Investors

In other news, CEO D. Eric Mendelsohn acquired 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction on Monday, June 15th. The shares were acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Algert Global LLC grew its stake in National Health Investors by 70.9% during the 2nd quarter. Algert Global LLC now owns 248,865 shares of the real estate investment trust’s stock valued at $18,978,000 after acquiring an additional 103,285 shares in the last quarter. Morgan Stanley Institutional Investment Advisors LLC acquired a new stake in National Health Investors in the 2nd quarter valued at about $5,943,000. Benchmark Investment Advisors LLC purchased a new position in National Health Investors in the 2nd quarter worth approximately $381,000. Commerce Bank purchased a new position in National Health Investors in the 2nd quarter worth approximately $386,000. Finally, Quantbot Technologies LP acquired a new position in shares of National Health Investors during the 2nd quarter worth approximately $863,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.